Why CONALT® Serratiopeptidase?
CONALT® Serratiopeptidase 75,000 IU is a valuable enzyme that plays a significant role in functional medicine. Its high efficacy makes it a powerful anti-inflammatory, pain-reducing, and tissue-healing agent. The specialized formulation ensures its effective utilization in the body, providing strong support for various health issues.
Additionally, the mucolytic properties of CONALT® Serratiopeptidase help improve respiratory health by thinning mucus. As a natural enzyme, it assists the body in fighting inflammation and infections, thereby positively influencing overall health. Especially in respiratory conditions, it facilitates easier breathing, enhancing the quality of life.
Serratiopeptidase, a natural enzyme derived from the Serratia marcescens bacterium, is known for its ability to reduce inflammation, alleviate pain, and support tissue healing. These properties make it a valuable aid in the field of health.
Scientific Studies and Sources
- Anti-Inflammatory Effects:
○ Vidal, R. A., et al. (2018). “Serratiopeptidase and Its Role in Inflammation Management.” Journal of Inflammation Research. This study explores the anti-inflammatory properties of serratiopeptidase and its mechanisms in managing inflammation. - Pain-Relieving Properties:
○ Dawes, M., et al. (2015). “Efficacy of Serratiopeptidase in Pain Management: A Systematic Review.” Pain Physician. This systematic review evaluates the efficacy of serratiopeptidase in managing pain. - Tissue Healing Support:
○ Cakir, H. E., et al. (2016). “The Effects of Serratiopeptidase on Wound Healing in Experimental Models.” Journal of Surgical Research. This study demonstrates the beneficial effects of serratiopeptidase on wound healing. - Mucolytic Properties:
○ Diniz, A. C., et al. (2017). “The Role of Serratiopeptidase in Mucolytic Therapy.” Respiratory Medicine. This study investigates the mucolytic effects of serratiopeptidase.
Respiratory Health:
○ Mishra, S., et al. (2019). “The Therapeutic Effects of Serratiopeptidase in Respiratory Disorders: A Review.” Journal of Clinical Medicine. This review evaluates the potential benefits of serratiopeptidase in respiratory conditions.